Cryogenic Vials Market: Growth Propped by Investments in Drug Development


Some of the prominent participants in the global cryogenic vials market are Thermo Fisher Scientific Inc., Corning Incorporated, DWK Life Sciences GmbH, Sigma-Aldrich Corporation, VWR International LLC, BioCision, LLC, Sumitomo Bakelite Co., Ltd., Starlab International GmbH, Capp ApS, Incell Technologies, Ziath Ltd, Argos Technologies, Inc., Azer Scientific, Inc., E&K Scientific Products, Inc., Evergreen Scientific, CELLTREAT Scientific Products, BIOLOGIX GROUP LTD, Abdos Labtech Private Limited, Simport Plastics Limited, and EZ Bio Research LLC.

A study by Transparency Market Research predicts the global cryogenic vial market to rise at a tepid pace. By clocking a CAGR of 3.9% during the period between 2017 and 2027, the market is expected to attain a value of US$199.3 mn by 2027-end from US$131.8 mn in 2016.

Depending upon the types of products, the global cryogenic vials market can be divided into self-standing and round-bottom. Of the two, the self-standing cryogenic vials dominate the market with over 50.0% share in it. Their greater uptake results from their eliminating the need for extra storage space – they do not require to be put in cryogenic racks which is mandatory for the round bottom cryogenic vials.

Geographically, the key segments of the global cryogenic vials market are North America, Latin America, Asia Pacific, Europe and the Middle East and Africa. Of them, North America leads with maximum share in the market. In the years ahead too, the region is expected to retain its dominant position by expanding its value at a CAGR of 4.2%. The growth in the region is being primarily powered by the increasing allocations on research and development of antibiotics. The U.S. is at the forefront of driving demand in the region on account of the major spends in development of new drugs.

Download Sample PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33014

Growing Spends on Research and Development of New Drugs Boost Demand

Majorly fuelling the global cryogenic vials market is the rising spends on research and development of new drugs by governments in key economies. Besides, cryopreservation feature of cryogenic vials, mainly needed for proteins, animal tissues, and cells which lose their chemical properties at room temperature and hence need to be preserved far below subzero temperature, is also boosting their demand. The cryogenic vials are safe for storing samples up to -196 degree centigrade.

Barcoding of Cryogenic Vials Leads to Uptake from Healthcare Institutions

“The ongoing trend observed in cryogenic vials market is that cryogenic vials are now being provided with the barcodes that facilitates easy identification. Also, barcoding of cryogenic vials aids in incorporation of data for future reference which has further propelled its application in the healthcare institutions,” adds the lead analyst of the TMR report.

Occasional Damage to Seal Integrity Serves to Reduce Demand

Cryogenic vials, however, suffer from certain drawbacks which is serving to hamper their demand. For example, sometimes they lose their seal integrity when they are immersed in liquid nitrogen, which results in cross contamination of liquid nitrogen with the biological sample. Also, prolonged storage of cryogenic vials in the liquid nitrogen may cause explosion. There have been instances where the leakage of vapors of liquid nitrogen has caused asphyxiation too.



©2014 News Liner. All rights reserved - Terms of Use | Privacy Policy | Help
Dessigned By The Colour Moon
social share buttons code